Ertuvia-S 15MG/100MG Tablets

Product Description

SPECIFICATION

Generics : Ertugliflozin + Sitagliptin

Used For : Diabetes

How it works : Ertugliflozin : Ertugliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Ertugliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Ertugliflozin also causes an osmotic diuresis, which may result in increase of urinary glucose excretion. Sitagliptin : Sitagliptin improve glycemic control in patients with type 2 diabetes by enhancing the levels of active incretin hormones. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), In addition, GLP-1 lowers glucagon secretion from pancreatic alpha cells. Decreased glucagon concentrations, along with higher insulin levels, lead to reduced hepatic glucose production, resulting in a decrease in blood glucose levels.

USAGE AND SAFETY

Dosage : Ertugliflozin + Sitagliptin

Side Effects : 

1. Dizziness
2. Fatigue
3. Headache
4. Dry cough
5. Changes in kidney function
6. Hyperkalemia (high levels of potassium in the blood)
7. Hypotension (low blood pressure)
8. Allergic reactions such as rash or itching

ADDITIONAL INFORMATION

Pregnancy category : Always consult your physician before using any medicine.

Storage (YES/NO) : Always consult your physician before using any medicine.